A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects

Preeti Pancholi, Steve Young, R. Widen, Suzane Silbert, B. Schmitt, R. Dunn, A. Drain, S. A. Weissfeld

Research output: Contribution to journalArticle

Abstract

We evaluated the performance of the Luminex ARIES® C. difficile Assay on 984 stool specimens prospectively collected from patients being tested for CDI at 4 clinical laboratories in the United States. Results were compared to direct and enriched toxigenic culture. Positive percent agreement (PPA) of the ARIES® C. difficile Assay was 98.1% versus direct toxigenic culture, and sensitivity versus direct plus enriched toxigenic culture was 90.5%. Negative percent agreement (NPA) of the ARIES® C. difficile Assay against direct culture was 92.6%, and specificity versus direct plus enriched toxigenic culture was 95.8%. The ARIES® C. difficile Assay was also compared to the results of routine (molecular, antigen, and/or toxin) methods for C. difficile testing used at each institution. The PPA of the ARIES® C. difficile Assay ranged from 82.9% to 100%. NPA values against these commercial assays ranged from 94.5% to 100%.

Original languageEnglish (US)
Article number114920
JournalDiagnostic Microbiology and Infectious Disease
Volume96
Issue number1
DOIs
StatePublished - Jan 2020
Externally publishedYes

Fingerprint

Real-Time Polymerase Chain Reaction
Antigens

Keywords

  • C. difficile
  • C. difficile infection
  • Luminex ARIES
  • NAAT
  • PCR

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects. / Pancholi, Preeti; Young, Steve; Widen, R.; Silbert, Suzane; Schmitt, B.; Dunn, R.; Drain, A.; Weissfeld, S. A.

In: Diagnostic Microbiology and Infectious Disease, Vol. 96, No. 1, 114920, 01.2020.

Research output: Contribution to journalArticle

Pancholi, Preeti ; Young, Steve ; Widen, R. ; Silbert, Suzane ; Schmitt, B. ; Dunn, R. ; Drain, A. ; Weissfeld, S. A. / A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects. In: Diagnostic Microbiology and Infectious Disease. 2020 ; Vol. 96, No. 1.
@article{52bae58d590346cbb0477b204f582cb2,
title = "A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects",
abstract = "We evaluated the performance of the Luminex ARIES{\circledR} C. difficile Assay on 984 stool specimens prospectively collected from patients being tested for CDI at 4 clinical laboratories in the United States. Results were compared to direct and enriched toxigenic culture. Positive percent agreement (PPA) of the ARIES{\circledR} C. difficile Assay was 98.1{\%} versus direct toxigenic culture, and sensitivity versus direct plus enriched toxigenic culture was 90.5{\%}. Negative percent agreement (NPA) of the ARIES{\circledR} C. difficile Assay against direct culture was 92.6{\%}, and specificity versus direct plus enriched toxigenic culture was 95.8{\%}. The ARIES{\circledR} C. difficile Assay was also compared to the results of routine (molecular, antigen, and/or toxin) methods for C. difficile testing used at each institution. The PPA of the ARIES{\circledR} C. difficile Assay ranged from 82.9{\%} to 100{\%}. NPA values against these commercial assays ranged from 94.5{\%} to 100{\%}.",
keywords = "C. difficile, C. difficile infection, Luminex ARIES, NAAT, PCR",
author = "Preeti Pancholi and Steve Young and R. Widen and Suzane Silbert and B. Schmitt and R. Dunn and A. Drain and Weissfeld, {S. A.}",
year = "2020",
month = "1",
doi = "10.1016/j.diagmicrobio.2019.114920",
language = "English (US)",
volume = "96",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects

AU - Pancholi, Preeti

AU - Young, Steve

AU - Widen, R.

AU - Silbert, Suzane

AU - Schmitt, B.

AU - Dunn, R.

AU - Drain, A.

AU - Weissfeld, S. A.

PY - 2020/1

Y1 - 2020/1

N2 - We evaluated the performance of the Luminex ARIES® C. difficile Assay on 984 stool specimens prospectively collected from patients being tested for CDI at 4 clinical laboratories in the United States. Results were compared to direct and enriched toxigenic culture. Positive percent agreement (PPA) of the ARIES® C. difficile Assay was 98.1% versus direct toxigenic culture, and sensitivity versus direct plus enriched toxigenic culture was 90.5%. Negative percent agreement (NPA) of the ARIES® C. difficile Assay against direct culture was 92.6%, and specificity versus direct plus enriched toxigenic culture was 95.8%. The ARIES® C. difficile Assay was also compared to the results of routine (molecular, antigen, and/or toxin) methods for C. difficile testing used at each institution. The PPA of the ARIES® C. difficile Assay ranged from 82.9% to 100%. NPA values against these commercial assays ranged from 94.5% to 100%.

AB - We evaluated the performance of the Luminex ARIES® C. difficile Assay on 984 stool specimens prospectively collected from patients being tested for CDI at 4 clinical laboratories in the United States. Results were compared to direct and enriched toxigenic culture. Positive percent agreement (PPA) of the ARIES® C. difficile Assay was 98.1% versus direct toxigenic culture, and sensitivity versus direct plus enriched toxigenic culture was 90.5%. Negative percent agreement (NPA) of the ARIES® C. difficile Assay against direct culture was 92.6%, and specificity versus direct plus enriched toxigenic culture was 95.8%. The ARIES® C. difficile Assay was also compared to the results of routine (molecular, antigen, and/or toxin) methods for C. difficile testing used at each institution. The PPA of the ARIES® C. difficile Assay ranged from 82.9% to 100%. NPA values against these commercial assays ranged from 94.5% to 100%.

KW - C. difficile

KW - C. difficile infection

KW - Luminex ARIES

KW - NAAT

KW - PCR

UR - http://www.scopus.com/inward/record.url?scp=85075475027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075475027&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2019.114920

DO - 10.1016/j.diagmicrobio.2019.114920

M3 - Article

C2 - 31699545

AN - SCOPUS:85075475027

VL - 96

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 1

M1 - 114920

ER -